Health
STAT+: What stands between brain implants and FDA approval?
In this edition of STAT Health Tech: The regulatory challenges faced by startups developing implanted brain-computer int...
Section
Health
Health
Health
STAT+: HHS adviser hopes prior authorization reform happens in ‘double-digit months,’ not years
A top federal health official said he hopes the Trump administration’s efforts to whittle down the insurance industry’s...
Health
STAT+: Digital twins, the holy grail of preventative health, are still only a ‘Frankensteinian proof of principle’
AI advances and new data on genomics, patient outcomes, and drug performance have pushed the idea of “digital twins” clo...
Health
STAT+: In earnings call, Hims CEO addresses scrutiny of GLP-1 compounding
In earnings call, Hims & Hers CEO Andrew Dudum addressed the increased scrutiny on compounded GLP-1s and its impact on t...
Health
STAT+: A provocative proposal asks the FDA to let some AI devices on the market without review
A provocative new proposal has offered the FDA a way to let a broad swath of potentially risky AI devices flood the mark...
Health
STAT+: An AI startup floats FDA deregulation, using an obscure backdoor
In this edition of STAT's Health Tech: An AI startup pushes for some AI-powered medical devices to be exempt from pre-ma...
Health
STAT+: AI-guided cancer treatments, telehealth usage, and other health tech news
In this edition of STAT Health Tech: A new wave of AI-guided cancer treatments, a Hims acquisition, and other health tec...
Health
STAT+: Hims to buy Eucalyptus as it looks to expand globally
Hims & Hers is buying the Australian telehealth firm Eucalyptus as it looks to make inroads in more countries globally.
Health
Opinion: STAT+: Sometimes, it would be unethical not to use AI in medicine
“We do not let pilots fly without instrument support simply because they technically could. Why should medicine be diffe...
Health
STAT+: In a financial pinch, major health insurers are turning to AI for help
Facing shrinking profits and higher costs, health insurers are accelerating adoption of AI throughout their sprawling op...
Health
STAT+: Researchers take another look at Apple’s hypertension feature
In this edition of STAT Health Tech: Fundraises by Talkiatry, Big Health, and the accuracy of Apple Watch hypertension f...
Health
STAT+: Does Medicare’s ACCESS model pay enough?
In this edition of STAT Health Tech: Payment rates for Medicare's ACCESS model, health insurers' use of AI, and more.
Health
STAT+: AI Prognosis: Who’s keeping tabs on how health insurers are using AI?
In this edition, AI Prognosis talks to STAT's Casey Ross, a Pulitzer finalist laser-focused on health insurers' use of A...
Health
STAT+: Does Medicare’s ACCESS model pay enough?
In this edition of STAT Health Tech: Payment rates for Medicare's ACCESS model, health insurers' use of AI, and more.
Health
STAT+: Researchers take another look at Apple’s hypertension feature
In this edition of STAT Health Tech: Fundraises by Talkiatry, Big Health, and the accuracy of Apple Watch hypertension f...
STAT+: Big Health raises funding as investors see glimmer of hope for digital therapeutics
Big Health raises $24 million as investors bet that digital therapeutics' time has finally arrived.
STAT+: Hims is in the crosshairs. Is a crackdown coming for compounding?
A federal regulatory crackdown on Hims could impact a broader network of compounding pharmacies and telehealth companies...
Health
STAT+: Why doctors and patients are having two totally different AI chatbot experiences
In this edition of STAT's AI Prognosis: Brittany Trang breaks down how AI models' performance differs by user, sometimes...